Description
About Levagen 4 Mg
Each capsule of Levagen 4mg contains Lenvatinib Mesylate INN equivalent to Lenvatinib 4mg. Lenvatinib is a kinase inhibitor that inhibits the kinase activity of vascular endothelial growth factor (VEGF) receptors. General Pharmaceuticals LTD is the manufacturer of Levagen 4mg. Each box of Levagen 4mg contains 30 capsules.
Dosage
Recommended dosage for Levagen 4 mg is one tablet orally twice daily, with or without food until disease progression or unacceptable toxicity. Whole capsule should be swallowed with water and the capsule should not be chewed or crushed. Or, as directed by the registered physician.
Side Effects
- Diarrhoea
- Hypertension
- Cardiac Dysfunction
- Hepatotoxicity
- Arterial Thromboembolic Events
- Proteinuria
- Hypocalcemia
- Renal Failure or Impairment
Storage
Levagen 4mg should be stored below 30°C in a dry and clean place, away from sunlight and out of the reach of children.
Reviews
There are no reviews yet.